549 related articles for article (PubMed ID: 18636071)
21. Discovery of novel human histamine H4 receptor ligands by large-scale structure-based virtual screening.
Kiss R; Kiss B; Könczöl A; Szalai F; Jelinek I; László V; Noszál B; Falus A; Keseru GM
J Med Chem; 2008 Jun; 51(11):3145-53. PubMed ID: 18459760
[TBL] [Abstract][Full Text] [Related]
22. Virtual screening - what does it give us?
Köppen H
Curr Opin Drug Discov Devel; 2009 May; 12(3):397-407. PubMed ID: 19396741
[TBL] [Abstract][Full Text] [Related]
23. I want a new drug: G-protein-coupled receptors in drug development.
Schlyer S; Horuk R
Drug Discov Today; 2006 Jun; 11(11-12):481-93. PubMed ID: 16713899
[TBL] [Abstract][Full Text] [Related]
24. Integrating virtual screening in lead discovery.
Oprea TI; Matter H
Curr Opin Chem Biol; 2004 Aug; 8(4):349-58. PubMed ID: 15288243
[TBL] [Abstract][Full Text] [Related]
25. The use of protein-ligand interaction fingerprints in docking.
Brewerton SC
Curr Opin Drug Discov Devel; 2008 May; 11(3):356-64. PubMed ID: 18428089
[TBL] [Abstract][Full Text] [Related]
26. Consensus scoring with feature selection for structure-based virtual screening.
Teramoto R; Fukunishi H
J Chem Inf Model; 2008 Feb; 48(2):288-95. PubMed ID: 18229906
[TBL] [Abstract][Full Text] [Related]
27. The effect of ligand-based tautomer and protomer prediction on structure-based virtual screening.
Kalliokoski T; Salo HS; Lahtela-Kakkonen M; Poso A
J Chem Inf Model; 2009 Dec; 49(12):2742-8. PubMed ID: 19928753
[TBL] [Abstract][Full Text] [Related]
28. Comparison of topological descriptors for similarity-based virtual screening using multiple bioactive reference structures.
Hert J; Willett P; Wilton DJ; Acklin P; Azzaoui K; Jacoby E; Schuffenhauer A
Org Biomol Chem; 2004 Nov; 2(22):3256-66. PubMed ID: 15534703
[TBL] [Abstract][Full Text] [Related]
29. Selective structure-based virtual screening for full and partial agonists of the beta2 adrenergic receptor.
de Graaf C; Rognan D
J Med Chem; 2008 Aug; 51(16):4978-85. PubMed ID: 18680279
[TBL] [Abstract][Full Text] [Related]
30. Molecular modelling of drug targets: the past, the present and the future.
Dahl SG; Sylte I
Basic Clin Pharmacol Toxicol; 2005 Mar; 96(3):151-5. PubMed ID: 15733208
[TBL] [Abstract][Full Text] [Related]
31. Atomic property fields: generalized 3D pharmacophoric potential for automated ligand superposition, pharmacophore elucidation and 3D QSAR.
Totrov M
Chem Biol Drug Des; 2008 Jan; 71(1):15-27. PubMed ID: 18069986
[TBL] [Abstract][Full Text] [Related]
32. Ligand-target interaction-based weighting of substructures for virtual screening.
Crisman TJ; Sisay MT; Bajorath J
J Chem Inf Model; 2008 Oct; 48(10):1955-64. PubMed ID: 18821751
[TBL] [Abstract][Full Text] [Related]
33. Focused library design in GPCR projects on the example of 5-HT(2c) agonists: comparison of structure-based virtual screening with ligand-based search methods.
Bissantz C; Schalon C; Guba W; Stahl M
Proteins; 2005 Dec; 61(4):938-52. PubMed ID: 16224780
[TBL] [Abstract][Full Text] [Related]
34. Improving the quality of 3D-QSAR by using flexible-ligand receptor models.
Pei J; Chen H; Liu Z; Han X; Wang Q; Shen B; Zhou J; Lai L
J Chem Inf Model; 2005; 45(6):1920-33. PubMed ID: 16309299
[TBL] [Abstract][Full Text] [Related]
35. Ligand-based combinatorial design of selective purinergic receptor (A2A) antagonists using self-organizing maps.
Schneider G; Nettekoven M
J Comb Chem; 2003; 5(3):233-7. PubMed ID: 12739938
[TBL] [Abstract][Full Text] [Related]
36. Rational ligand-based virtual screening and structure-activity relationship studies in the ligand-binding domain of the glucocorticoid receptor-α.
Onnis V; Kinsella GK; Carta G; Fayne D; Lloyd DG
Future Med Chem; 2009 Jun; 1(3):483-99. PubMed ID: 21426128
[TBL] [Abstract][Full Text] [Related]
37. Using molecular docking, 3D-QSAR, and cluster analysis for screening structurally diverse data sets of pharmacological interest.
Santos-Filho OA; Cherkasov A
J Chem Inf Model; 2008 Oct; 48(10):2054-65. PubMed ID: 18816024
[TBL] [Abstract][Full Text] [Related]
38. Modeling small molecule-compound binding to G-protein-coupled receptors.
Vaidehi N; Pease JE; Horuk R
Methods Enzymol; 2009; 460():263-88. PubMed ID: 19446730
[TBL] [Abstract][Full Text] [Related]
39. Multi-dimensional QSAR in drug discovery.
Lill MA
Drug Discov Today; 2007 Dec; 12(23-24):1013-7. PubMed ID: 18061879
[TBL] [Abstract][Full Text] [Related]
40. High-throughput screening of interactions between G protein-coupled receptors and ligands using confocal optics microscopy.
Zemanová L; Schenk A; Valler MJ; Nienhaus GU; Heilker R
Methods Mol Biol; 2005; 305():365-84. PubMed ID: 15940007
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
